(Senior) Associate Scientist or Scientist, Biology

(Senior) Program Manager

1910 Genetics

20n Bio

3DBio Therapeutics

3T Biosciences

4D Molecular Therapeutics

64x Bio

76Bio

A-Alpha Bio

A2 Biotherapeutics

AAVogen

ACELYRIN

AI Proteins

AIRNA Bio

ALX Oncology

AN2 Therapeutics

AOA Dx

ARTBIO

AUM BioTech

AVROBIO

Ab Studio

Abalone Bio

Abata Therapeutics

Abeona Therapeutics

Abintus Bio

Abiosciences

Absci

Accelevir Diagnostics

Accent Therapeutics

Acepodia

Achieve Life Sciences

Acomhal Research

Acrivon Therapeutics

Actym Therapeutics, Inc.

Acutis Diagnostics

Adaptive Phage Therapeutics

Adcentrx Therapeutics

Adicet Bio

Aditum Bio

Admera Health

Adverum Biotechnologies

Aeglea BioTherapeutics

Aether Bio

Affini-T Therapeutics

Affinia Therapeutics

Affinivax

AgBiome

Agastiya Biotech

Agena Bioscience

AiViva Biopharma

Ainnocence

AivoCode

Aixa Bio

Akero Therapeutics

Akita Biosciences

Akouos

Alamar Biosciences

Alector

Alida Biosciences

AlivaMab Discovery Services

Alkahest

Alladapt Immunotherapeutics

Allakos

Allarta Life Science

Allay Therapeutics

AlloVir

Alloy Therapeutics

Alltrna

AlpaLifeBio

Alpha-9 Oncology

Alphabioregen

Alpine Immune Sciences

AltPep

Alterome Therapeutics

Altis Biosystems

Alto Neuroscience

Alumis

Alveo Technologies

Alveolus Bio

Alzheon

AmbAgon Therapeutics

Amberstone Biosciences

Amolyt Pharma

Amylyx Pharmaceuticals

AnHeart Therapeutics

Anagram Therapeutics

Ancora Biotech LLC

Andes

Andson Biotech

Anebulo Pharmaceuticals

Angiex

Angiocrine Bioscience

Anima Biotech

Ankyra

Annexon Biosciences

Anodyne Nanotech

Anokion

Ansa Biotechnologies

Antheia

Anthos Therapeutics

Apaxon Biotech LLC

Variant Bio is leveraging cutting-edge genomics and computational biology to discover and develop novel therapeutics for rare diseases. Their unique approach leverages the power of genomics to identify individuals with exceptional health traits and uncover the underlying genetic mechanisms responsible for these traits. Combining various types of biological data to identify causal genes and establish disease mechanisms. Their proprietary, VB-Inference platform, uses advanced analytics to infer causal relationships from complex genetic data. Variant Bio's reliance on multi-omic data and advanced analytics provides a robust foundation for drug discovery. Variant Bio has a pipeline of drug candidates targeting various diseases, including rare genetic disorders and neurodegenerative conditions.

<p>Variant Bio is using genetic differences to identify therapies to improve health. The human population has a variety of exceptional traits. This ranges from diabetes protection, low cholesterol, Cholera resistance to strong bones. Variant Bio is pioneering people-driven therapeutics that uses human diversity to identify the basis of disease and resistance to it. This requires studying the genomes of people with exceptional health-related traits that can inspire new therapies to lower cholesterol and treat osteoporosis, for example. Variant Bio is using innovative whole-genome sequencing and custom algorithms that can identify novel and population-specific genetic variants to go from genomes to targets.</p>


Find a biotech startup job.